Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Phoebe J Ho

17PUBLICATIONS

94CO-AUTHORS

Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical microbiology not elsewhere classified

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jun 08, 2026

Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry.

|May 05, 2026

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Feb 17, 2026

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Nov 18, 2025

Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.

Richard T Maziarz, Michael R Bishop, Constantine S Tam

|Nov 08, 2025

No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry.

Sueh-Li Lim, Cameron Wellard, Rajeev Rajagopal

|Aug 05, 2025

Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials.

María-Victoria Mateos, Suzanne Trudel, Hang Quach

Pageof 3

Frequent Collaborators

4 joint publications

Elizabeth Moore

4 joint publications

Zoe McQuilten

4 joint publications

Andrew Spencer

4 joint publications

Hang Quach

4 joint publications

Simon James Harrison

4 joint publications

Michael J Dickinson

3 joint publications

Joseph P McGuirk

2 joint publications

Marie José Kersten

2 joint publications

Takanori Teshima

2 joint publications

Anna Nelson

Frequent Collaborators

4 joint publications

Elizabeth Moore

4 joint publications

Zoe McQuilten

4 joint publications

Andrew Spencer

4 joint publications

Hang Quach